Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2021-02-22
SNSESensei Biotherapeutics, Inc.Cambrian Biopharma Inc10%P - Purchase$18.88+9,8024,712,4940%+$185,062
2021-02-22
SNSESensei Biotherapeutics, Inc.Peyer JamesDir, 10%P - Purchase$18.88+9,8024,712,4940%+$185,062
M
2021-02-22
SDGRSchrodinger, Inc.Shaw David E10%S - Sale$112.24-457,6938,862,154-5%-$51,373,433
DM
2021-02-22
SDGRSchrodinger, Inc.Daniel JenniferSVP, CHROS - Sale+OE$108.96-6,6886,688-50%-$728,724
2021-02-22
ARWRArrowhead Pharmaceuticals, Inc.Given Douglas BDirS - Sale$88.73-1,125145,743-1%-$99,821
D
2021-02-22
ABBVAbbvie Inc.Sorg Elaine K.SVP, US Commercial OperationsS - Sale+OE$104.72-20,19532,751-38%-$2,114,732
M
2021-02-22
HGENHumanigen, IncNomis Bay Ltd.10%S - Sale$22.29-103,2205,662,542-2%-$2,301,023
DM
2021-02-22
STOKStoke Therapeutics, Inc.Tulipano Stephen JCFOS - Sale+OE$58.86-30,000602-98%-$1,765,896
2021-02-22
FOLDAmicus Therapeutics, Inc.Crowley John FCOB, CEOS - Sale$11.98-7,682909,101-1%-$92,027
2021-02-22
CARACara Therapeutics, Inc.Goncalves JoanaChief Medical OfficerS - Sale$19.73-2,00026,075-7%-$39,460
D
2021-02-22
MRSNMersana Therapeutics, Inc.Lowinger Timothy BChief Science, Tech. OfficerS - Sale+OE$20.01-8,20331,444-21%-$164,142
2021-02-22
ARDXArdelyx, Inc.Blanks RobertSee RemarksS - Sale$6.88-593112,729-1%-$4,081
2021-02-22
ARDXArdelyx, Inc.Jacobs Jeffrey WChief Scientific OfficerS - Sale$6.88-702124,772-1%-$4,832
2021-02-22
ARDXArdelyx, Inc.Rodriguez SusanChief Commercial OfficerS - Sale$6.88-61145,914-1%-$4,205
2021-02-22
ARDXArdelyx, Inc.Raab MichaelPres, CEOS - Sale$6.88-2,534242,652-1%-$17,440
2021-02-22
ARDXArdelyx, Inc.Rosenbaum David P.Chief Development OfficerS - Sale$6.88-805272,6080%-$5,540
2021-02-22
ARDXArdelyx, Inc.Renz Justin ACFOS - Sale$6.88-60841,290-1%-$4,185
2021-02-22
ARDXArdelyx, Inc.Grammer Elizabeth ASee RemarksS - Sale$6.88-504106,3910%-$3,469
D
2021-02-22
FULCFulcrum Therapeutics, Inc.Thomson Peter G.VP Finance, AccountingS - Sale+OE$14.72-5,00015,212-25%-$73,582
D
2021-02-22
BPMCBlueprint Medicines CorpDorsch MarionChief Scientific OfficerS - Sale+OE$100.00-7,57815,250-33%-$757,800
2021-02-22
ARQTArcutis Biotherapeutics, Inc.Chaudhuri BhaskarDirS - Sale$35.52-10,000931,372-1%-$355,191
2021-02-15
QUREUniqure N.V.Kapusta Matthew CCEO, CFO, MDS - Sale$35.38-3,800222,938-2%-$134,452
2021-02-23
MEIPMei Pharma, Inc.Driscoll Frederick WDirS - Sale$4.03-25,00037,500-40%-$100,625
2021-02-23
SCPSScopus Biopharma Inc.Lamstein Joshua RCOBP - Purchase$9.34+500117,2970%+$4,670
2021-02-19
APLTApplied Therapeutics Inc.Kanter Stacy J.DirP - Purchase$22.86+6,50013,000+100%+$148,590
2021-02-23
SCPSScopus Biopharma Inc.Greenspan IRA ScottExec Committee COBP - Purchase$9.65+1,50087,325+2%+$14,474
D
2021-02-22
ABTAbbott LaboratoriesMoreland Mary KEVPS - Sale+OE$121.83-40086,5320%-$48,734
2021-02-19
ZTSZoetis Inc.Scully Robert WDirP - Purchase$164.68+7,5907,590New+$1,249,931
2021-02-22
HZNPHorizon Therapeutics Public Ltd CoKarnani VikramEVP, Pres, InternationalS - Sale$87.19-8,358104,165-7%-$728,722
2021-02-22
HZNPHorizon Therapeutics Public Ltd CoKonstantinovsky IrinaEVP, Chief HR OffS - Sale$87.22-5,69881,677-7%-$496,987
M
2021-02-19
PHATPhathom Pharmaceuticals, Inc.Socks David ADirS - Sale$46.49-70,0001,436,048-5%-$3,254,612
D
2021-02-22
NRIXNurix Therapeutics, Inc.Van Houte HansCFOS - Sale+OE$39.93-5,3300-100%-$212,839
DM
2021-02-19
CNSTConstellation Pharmaceuticals IncReeve EmmaCFOS - Sale+OE$37.64-10,2700-100%-$386,591
D
2021-02-19
STOKStoke Therapeutics, Inc.Tzianabos ArthurDirS - Sale+OE$60.67-10,0000-100%-$606,652
2021-02-22
SDGRSchrodinger, Inc.Tran YvonneEVP, GCS - Sale$113.66-10,00017,131-37%-$1,136,586
DM
2021-02-19
OMEROmeros CorpJacobsen Michael AVP Finance, CAOS - Sale+OE$22.93-18,10014,000-56%-$414,968
DM
2021-02-19
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale+OE$3.68-14,757634,900-2%-$54,369
D
2021-02-19
ZTSZoetis Inc.Alaix Juan RamonDirS - Sale+OE$160.55-133,070214,307-38%-$21,363,973
DM
2021-02-19
KINKindred Biosciences, Inc.Bevers DeniseDirS - Sale+OE$5.00-4,627143,835-3%-$23,135
DM
2021-02-19
SPPISpectrum Pharmaceuticals IncMcGahan Keith MGCS - Sale+OE$3.69-7,295353,762-2%-$26,904
DM
2021-02-19
SPPISpectrum Pharmaceuticals IncGustafson Kurt AEVP, CFOS - Sale+OE$3.68-8,672448,974-2%-$31,912
2021-02-22
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$2.43-20,00024,838,5460%-$48,614
DM
2021-02-19
SPPISpectrum Pharmaceuticals IncRiga Thomas JEVP, COO, CCOS - Sale+OE$3.68-10,018468,789-2%-$36,900
2021-02-19
SNSESensei Biotherapeutics, Inc.Peyer JamesDir, 10%P - Purchase$19.77+11,7864,702,6920%+$233,009
2021-02-19
SNSESensei Biotherapeutics, Inc.Cambrian Biopharma Inc10%P - Purchase$19.77+11,7864,702,6920%+$233,009
D
2021-02-19
ABEOAbeona Therapeutics Inc.Mann Paul ElliotDirS - Sale+OE$2.38-45,5660-100%-$108,502
2021-02-19
ABEOAbeona Therapeutics Inc.Wider ToddDirS - Sale$2.39-251,62525,000-91%-$601,057
A
2021-02-18
PRTAProthena Corp Public Ltd CoEcor1 Capital, LLC10%P - Purchase$23.65+44,10010,104,0800%+$1,043,075
D
2021-02-19
RAREUltragenyx Pharmaceutical Inc.Aliski WilliamDirS - Sale+OE$149.01-7,500145,510-5%-$1,117,575
M
2021-02-19
MORFMorphic Holding, Inc.Omega Fund V, L.P.DirS - Sale$35.18-10,8592,598,0920%-$382,044
2021-02-22
SVRASavara IncPauls MatthewCEOP - Purchase$1.74+28,700256,622+13%+$50,038
2021-02-22
SCPSScopus Biopharma Inc.Lamstein Joshua RCOBP - Purchase$9.99+100116,7970%+$999
2021-02-22
SCPSScopus Biopharma Inc.Greenspan IRA ScottExec Committee COBP - Purchase$10.05+4505,350+9%+$4,523
2021-02-09
CBIOCatalyst Biosciences, Inc.Usman NassimPres, CEOP - Purchase$4.81+58221,798+3%+$2,799
2021-02-09
CBIOCatalyst Biosciences, Inc.Levy HowardChief Medical OfficerP - Purchase$4.81+1,67023,390+8%+$8,033
D
2021-02-19
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$83.58-7,000543,085-1%-$585,060
M
2021-02-18
PCSAProcessa Pharmaceuticals, Inc.Besser James E10%S - Sale$11.49-28,9291,501,071-2%-$332,289
2021-02-18
KPTIKaryopharm Therapeutics Inc.Shah JatinEVP, Chief Medical OfficerS - Sale$14.83-1,18651,791-2%-$17,590
2021-02-18
KPTIKaryopharm Therapeutics Inc.Frenkel RanEVP, Chief Dev. OfficerS - Sale$14.83-2,88746,126-6%-$42,818
2021-02-18
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale$14.83-18,9901,351,578-1%-$281,644
D
2021-02-19
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.Chief Medical OfficerS - Sale+OE$39.25-2,73423,104-11%-$107,310
2021-02-18
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale$14.83-18,9901,351,578-1%-$281,644
D
2021-02-19
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerS - Sale+OE$39.22-5,18445,339-10%-$203,308
D
2021-02-19
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOS - Sale+OE$39.23-10,4420-100%-$409,625
D
2021-02-19
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP, GCS - Sale+OE$39.24-11,1390-100%-$437,133
D
2021-02-19
ITCIIntra-Cellular Therapies, Inc.Mates SharonCOB, Pres, CEOS - Sale+OE$39.23-27,8471,133,392-2%-$1,092,436
D
2021-02-19
SDGRSchrodinger, Inc.D'Cruz ConyEVP, Chief Business OfficerS - Sale+OE$102.00-4,800153,082-3%-$489,600
D
2021-02-19
ZTSZoetis Inc.Lagano RoxanneEVPS - Sale+OE$167.88-6,00042,083-12%-$1,007,280
D
2021-02-18
ZTSZoetis Inc.Chen Heidi C.EVPS - Sale+OE$170.04-60024,645-2%-$102,024
2021-02-18
PRTAProthena Corp Public Ltd CoEcor1 Capital, LLC10%P - Purchase$3.68+44,10010,104,0800%+$162,103
D
2021-02-18
NRIXNurix Therapeutics, Inc.Van Houte HansCFOS - Sale+OE$35.46-13,5830-100%-$481,621
D
2021-02-18
NRIXNurix Therapeutics, Inc.Ring ChristineGCS - Sale+OE$35.88-2,0000-100%-$71,750
D
2021-02-18
NRIXNurix Therapeutics, Inc.Hansen GwennChief Scientific OfficerS - Sale+OE$36.27-80012,000-6%-$29,018
D
2021-02-18
NRIXNurix Therapeutics, Inc.Beaurang PierreChief Business OfficerS - Sale+OE$35.49-15,0000-100%-$532,352
D
2021-02-19
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$4.77+500,000225,067,8220%+$2,383,455
D
2021-02-18
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$85.08-7,000543,085-1%-$595,560
D
2021-02-17
BCELAtreca, Inc.Greenberg Norman MichaelChief Scientific OfficerS - Sale+OE$18.95-5,0000-100%-$94,752
M
2021-02-17
SDGRSchrodinger, Inc.Shaw David E10%S - Sale$102.64-342,7599,319,847-4%-$35,179,809
D
2021-02-17
BTAIBioxcel Therapeutics, Inc.O'Neill VincentChief Medical OfficerS - Sale+OE$55.58-25,0000-100%-$1,389,459
D
2021-02-17
FGENFibrogen IncKurkijarvi KaleviDirS - Sale+OE$52.40-6,00033,100-15%-$314,383
D
2021-02-17
DBTXDecibel Therapeutics, Inc.Orbimed Advisors LLCDir, 10%P - Purchase$18.00+1,666,666883,418-213%+$29,999,988
D
2021-02-17
DBTXDecibel Therapeutics, Inc.Foy MatthewDir, 10%P - Purchase$18.00+150,0001,183,663+15%+$2,700,000
D
2021-02-17
DBTXDecibel Therapeutics, Inc.Casdin Partners Master Fund, L.P.10%P - Purchase$18.00+575,0001,121,421+105%+$10,350,000
D
2021-02-17
DBTXDecibel Therapeutics, Inc.Thompson Peter A.Dir, 10%P - Purchase$18.00+1,666,666883,418-213%+$29,999,988
D
2021-02-18
PRTAProthena Corp Public Ltd CoZago Wagner M.Chief Scientific OfficerS - Sale+OE$25.50-7,5400-100%-$192,270
2021-02-17
VRPXVirpax Pharmaceuticals, Inc.Jacob Gary SDirP - Purchase$6.79+3,5003,500New+$23,762
M
2021-02-17
HGENHumanigen, IncNomis Bay Ltd.10%S - Sale$22.25-89,4085,765,762-2%-$1,989,619
2021-02-17
CNSTConstellation Pharmaceuticals IncColumn Group L P10%S - Sale$36.95-10,0006,230,6380%-$369,503
2021-02-17
CNSTConstellation Pharmaceuticals IncColumn Group L P10%S - Sale$36.95-10,0006,230,6380%-$369,503
2021-02-18
MTEMMolecular Templates, Inc.Biotech Target N V10%P - Purchase$12.65+1,185,7707,726,101+18%+$14,999,991
2021-02-18
GRTXGalera Therapeutics, Inc.Novo Holdings A/s10%S - Sale$10.58-500,0002,459,021-17%-$5,290,000
2021-02-17
CRVSCorvus Pharmaceuticals, Inc.Orbimed Advisors LLCDir, 10%P - Purchase$3.50+1,285,7148,053,298+19%+$4,499,999
D
2021-02-17
DBTXDecibel Therapeutics, Inc.Glaxosmithkline PlcDirP - Purchase$18.00+150,0001,183,663+15%+$2,700,000
2021-02-17
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.Dir, 10%P - Purchase$3.50+1,285,7148,053,298+19%+$4,499,999
D
2021-02-17
NEXINeximmune, Inc.Jones KristiCOOP - Purchase$17.00+91163,078+1%+$15,487
2021-02-17
NEXINeximmune, Inc.Zeldis Jerome BEVP of Research, DevP - Purchase$17.00+5,8825,882New+$99,994
D
2021-02-17
NEXINeximmune, Inc.Verstandig GrantDirP - Purchase$17.00+175,000714,895+32%+$2,975,000
2021-02-18
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, Chief Accounting OfficerS - Sale$211.83-4,29516,997-20%-$909,828
D
2021-02-17
NEXINeximmune, Inc.Barer Sol JDirP - Purchase$17.00+60,0003,252,404+2%+$1,020,000
2021-02-18
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, Chief Patient OfficerS - Sale$211.83-9,26454,915-14%-$1,962,366

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top